Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Last funding type
IPO status
Contacts
Similar Companies1000
ONL Therapeutics
ONL Therapeutics develops therapeutics for retinal diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
LENZ Therapeutics
LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision.
Sector
Subsector
Keywords
Location
total rounds
total raised
OcuCure Therapeutics
OcuCure Therapeutics is developing topical eye drops for the treatment of age-related macular degeneration and diabetic retinopathy.
Sector
Subsector
Keywords
Location
total rounds
total raised
Kuria Therapeutics
Kuria Therapeutics is a pharmaceutical company developing a novel topical Nrf2 activator for eye and skin diseases.
Sector
Subsector
Keywords
Location
total rounds
Financials
Funding Rounds2
Number of Funding Rounds
Money Raised
Their latest funding was raised on 10.08.2021. Their latest investor Johnson & Johnson Innovation – JJDC. Their latest round Debt Financing
Life Sciences Partners
LSP is a leading European investment firm that finances private and public life-science companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
RTW Investments LLC
RTW Investments is an innovative health care investment firm.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors5
Number of lead investors
Number of investors
Johnson & Johnson Innovation – JJDC
JJDC helps innovative healthcare ideas become real solutions for patients.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
RTW Investments LLC
RTW Investments is an innovative health care investment firm.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Tony Nguyen
Tony Nguyen is a managing director at RTW Investments. He serves as an Analyst at RTW, where he leads the commercial analysis of biopharma and medical technology assets. He is also the founding member of the firm’s internal Valuation Committee. Tony’s focus on the commercial viability of new drugs and technologies is a critical component of RTW’s work. We are living in an age where diseases are being redefined based on their genetic causes, and it is of paramount importance to understand the changing opportunity set of addressable patients across diseases. Tony received a BS in Electrical Engineering from the National University of Singapore and an MBA from St. John’s University, both on a full academic scholarship. POST NAVIGATION
Wille AG
Wille AG
Location
count Of Investments
count Of Exists
People
Founders1
Benjamin Bergo
Ben Bergo is the Co-Founder, Executive Director, Chief Executive Officer & Board Member at Visus Therapeutics.
current job
organization founded
Benjamin Bergo
Employee Profiles3
Jehan Tamboowalla
SVP, Head of Business Development and Marketing
Benjamin Bergo
Co-Founder, Executive Director, Chief Executive Officer & Board Member
Activity
Recent News6
The graph reveals the ratio (%) of positive news articles in a chosen time range